Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Redhill Biopharma Ltd RDHL

Healthcare
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204... see more

Recent & Breaking News (NDAQ:RDHL)

RedHill Biopharma to Present at the Jefferies 2015 Global Healthcare Conference

GlobeNewswire May 27, 2015

RedHill Biopharma's Investor Webcast Forum Provides Update on the RHB-105 Phase III Program and Potential H. Pylori Eradication Market

GlobeNewswire May 18, 2015

RedHill Biopharma to Present at the BioTrinity 2015 Partnering Conference

GlobeNewswire May 8, 2015

RedHill Biopharma to Host Investor Webcast Forum Following Completion of RHB-105 Dosing in Phase III Study

GlobeNewswire May 7, 2015

RedHill Biopharma to Present at the Oppenheimer 16th Annual Israeli Conference

GlobeNewswire May 4, 2015

RedHill Biopharma Reports Results for the First Quarter of 2015

GlobeNewswire April 30, 2015

RedHill Biopharma to Present at the BioNetwork East 2015 Partnering Conference

GlobeNewswire April 28, 2015

RedHill Biopharma Announces Completion of Patient Enrollment in a Phase III Study of RHB-105 for H. pylori Infection

GlobeNewswire April 27, 2015

RedHill Biopharma to Host First Quarter 2015 Financial Results Conference Call on April 30, 2015

GlobeNewswire April 21, 2015

RedHill Biopharma Receives Notice of Allowance for Additional U.S. Patent for RHB-105 H. pylori Bacterial Infection Treatment

GlobeNewswire April 16, 2015

RedHill Biopharma Acquires Phase II First-in-Class Oral Small Molecule SK2 Inhibitor From Apogee Biotech

GlobeNewswire March 31, 2015

RedHill Biopharma to Present at the 3rd Annual Autoimmune & Inflammation Leaders' Forum 2015

GlobeNewswire March 23, 2015

New Market Trends in Biotech, Entertainment, and Organic Food

Marketwired March 5, 2015

RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015

Canada NewsWire March 3, 2015

5 Live Investor Webcasts from Aflac and Life Sciences Companies: March 5 at VirtualInvestorConferences.com

Canada NewsWire March 3, 2015

RedHill Biopharma to Present at Bio-Europe Spring 2015 International Partnering Conference

GlobeNewswire March 3, 2015

RedHill Biopharma to Present at the 27th Annual ROTH Conference

GlobeNewswire March 3, 2015

Positive Bioavailability Studies of RedHill's BEKINDA(TM) to be Presented at the 2015 American Society for Clinical Pharmacology and Therapeutics (ASCPT) Meeting

GlobeNewswire March 2, 2015

RedHill Biopharma Reports 2014 Fourth Quarter and Year-End Financial Results

GlobeNewswire February 26, 2015

RedHill Biopharma to Host 2014 Fourth Quarter and Year-End Financial Results Conference Call on February 26, 2015

GlobeNewswire February 19, 2015